Generics Archives - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

Apotex Leads Race for Generic Ozempic with Tentative FDA Approval

Vimy Pharma to Launch Made-In-Canada Ozempic Generic

October 24, 2025

Life Science News

FDA Rejects Novartis’ Latest Bid to Block Entresto Generic

October 21, 2024

Several ADHD Generics Get FDA Green Light as Takeda’s Vyvanse Loses Market Exclusivity

August 31, 2023

Business & Finance News

Mayne Pharma’s Generic Prescription Portfolio to Be Acquired by Dr. Reddy’s Laboratories

Life Science News

AvKARE Recall: Erectile Dysfunction Drug and Antidepressant Mistakenly Packaged Together

December 14, 2020

Business & Finance News

20 Generic Drug Manufacturers Sued by US States for Price Hikes

Life Science News

Mylan’s Generic Advair Breathes New Life into Asthma Market

Life Science News

Cheaper Generic EpiPen, Symjepi, Ready to Hit US Markets

January 24, 2019

Generic Sabril, an Anti-Seizure Drug, gets FDA Approval

January 23, 2019

Business & Finance News

Healthcare Spending on Branded Prescription Drugs Continues to Rise Despite Availability of More Generics

November 19, 2018

Business & Finance News

Teva Postpones One Third of Israeli Layoffs Until 2019

October 11, 2018

What the Top 10 Most Popular Prescriptions of 2018 Can Tell Us About the Health of the Nation

August 30, 2018

Teva’s Generic EpiPen Approved by FDA Just in Time for Back-to-School

August 24, 2018

Drug Shortages Push FDA to Consider Financial Incentives as Possible Solution

Life Science News

Novartis and Sandoz Recall 12 Different Drugs Over Faulty Child-Resistant Blister Packs

Next Page »